Intradialytic hypertension is a marker of volume excess.
BACKGROUND
Intradialytic blood pressure (BP) profiles have been associated with all-cause mortality, but its pathophysiology remains unknown. We tested the hypothesis that intradialytic changes in BP reflect excess volume.


METHODS
The dry weight reduction in hypertensive haemodialysis patients (DRIP) trial probed dry weight in 100 prevalent haemodialysis patients; 50 patients who did not have their dry weight probed served as time controls. In this post hoc analysis, intradialytic BP was recorded at each of the 30 dialysis treatments during the trial. The slope of intradialytic BP over dialysis was calculated by the log of BP regressed over time. Using a linear mixed model, we compared these slopes between control and ultrafiltration groups at baseline and over time, tested the effect of dry weight reduction on these slopes and finally tested the ability of change in intradialytic slopes to predict change in interdialytic systolic BP.


RESULTS
At baseline, intradialytic systolic and diastolic BP dropped at a rate of ~3%/h (P < 0.0001). Over the course of the trial, compared to the control group, the slopes steepened in the ultrafiltration group for systolic but not diastolic BP. Those who lost the most post-dialysis weight from baseline to 4 weeks and baseline to 8 weeks also experienced the greatest steepening of slopes. Each percent per hour steepening of the intradialytic systolic BP slope was associated with 0.71 mmHg [95% confidence interval (CI) 0.01-1.42, P = 0. 048] reduction in interdialytic ambulatory systolic pressure.


CONCLUSIONS
Intradialytic BP changes appear to be associated with change in dry weight among haemodialysis patients. Among long-term haemodialysis patients, intradialytic hypertension may, thus, be a sign of volume overload.
Agarwal
Rajiv
R
Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. ragarwal@iupui.edu
Light
Robert P
RP
D000959:Antihypertensive Agents / Q000627:therapeutic use; D018660:Blood Pressure Monitoring, Ambulatory; D003971:Diastole; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D013599:Systole
D000959:Antihypertensive Agents
J Am Soc Nephrol. 1999 Feb;10(2):392-403
10215341
Am J Kidney Dis. 2000 Nov;36(5):983-90
11054355
Kidney Int. 2002 Feb;61(2):697-704
11849413
Am J Kidney Dis. 2007 Jul;50(1):108-18, 118.e1-4
17591530
Am J Kidney Dis. 1986 Oct;8(4):244-7
3532771
Am J Kidney Dis. 2009 Nov;54(5):788-91
19853196
Am J Nephrol. 2008;28(5):792-801
18477842
Hypertension. 2009 Mar;53(3):500-7
19153263
Am J Kidney Dis. 1995 Aug;26(2):321-6
7645536
Nephrol Dial Transplant. 1997 Mar;12(3):485-91
9075129
Kidney Int. 2006 May;69(10):1833-8
16691262
Nephrol Dial Transplant. 1995;10(8):1417-20
8538935
Clin J Am Soc Nephrol. 2006 May;1(3):389-98
17699236
Am J Kidney Dis. 2010 Mar;55(3):580-9
19853337
Kidney Int. 1999 Apr;55(4):1528-35
10201019
Am J Kidney Dis. 2009 Nov;54(5):881-90
19643520
Nephrol Dial Transplant. 1996;11 Suppl 2:16-9
8803988
Am J Kidney Dis. 2002 Aug;40(2):291-301
12148101
Clin J Am Soc Nephrol. 2008 Jan;3(1):153-8
18057304